ATE347398T1 - Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung - Google Patents

Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung

Info

Publication number
ATE347398T1
ATE347398T1 AT02425379T AT02425379T ATE347398T1 AT E347398 T1 ATE347398 T1 AT E347398T1 AT 02425379 T AT02425379 T AT 02425379T AT 02425379 T AT02425379 T AT 02425379T AT E347398 T1 ATE347398 T1 AT E347398T1
Authority
AT
Austria
Prior art keywords
ophthalmic solution
carboxy methyl
containing ophthalmic
methyl beta
glucan containing
Prior art date
Application number
AT02425379T
Other languages
English (en)
Inventor
Luigi Mercuri
Original Assignee
Dmg Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dmg Italia Srl filed Critical Dmg Italia Srl
Application granted granted Critical
Publication of ATE347398T1 publication Critical patent/ATE347398T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT02425379T 2002-06-10 2002-06-10 Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung ATE347398T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02425379A EP1421974B1 (de) 2002-06-10 2002-06-10 Carboxy Methyl Beta-1,3 Glucan enthaltende ophthalmische Lösung

Publications (1)

Publication Number Publication Date
ATE347398T1 true ATE347398T1 (de) 2006-12-15

Family

ID=32187303

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02425379T ATE347398T1 (de) 2002-06-10 2002-06-10 Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung

Country Status (5)

Country Link
EP (1) EP1421974B1 (de)
AT (1) ATE347398T1 (de)
DE (1) DE60216612T2 (de)
ES (1) ES2276906T3 (de)
PT (1) PT1421974E (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008010241A1 (en) * 2006-07-18 2008-01-24 D.M.G. Italia Srl A liposomal complex of sodium carboxymethyl beta-glucan
EP2229180A1 (de) * 2007-12-27 2010-09-22 D.M.G. Italia Srl Zusammensetzung mit superoxid-dismutase und carboxy-methyl-beta-1,3-glucan
ITRM20110105A1 (it) * 2011-03-03 2012-09-04 Sooft Italia Spa Composizione ed uso di collirio antiedemigeno a base di acido lattobionico

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4946450A (en) * 1989-04-18 1990-08-07 Biosource Genetics Corporation Glucan/collagen therapeutic eye shields
GB9403153D0 (en) * 1994-02-18 1994-04-06 Ciba Geigy Ag Cosmetic compositions
DK1197216T3 (da) * 1996-07-19 2004-08-30 Mibelle Ag Cosmetics Farmaceutisk ellere kosmetisk sammensætning, der indholder polymere glucanetherderivater
US6599879B1 (en) * 1998-02-13 2003-07-29 Human Genome Sciences, Inc. Therapeutic uses of keratinocyte growth factor-2
WO2000054747A2 (en) * 1999-03-18 2000-09-21 Bausch & Lomb Incorporated Method for treating dry eye
IT1307281B1 (it) * 1999-11-25 2001-10-30 Simonelli Giuseppe Uso di ubichinone q10 per il trattamento locale e la prevenzione dipatalogie oftalmologiche secondarie alla terapia fotorefrattiva,

Also Published As

Publication number Publication date
ES2276906T3 (es) 2007-07-01
PT1421974E (pt) 2007-03-30
DE60216612T2 (de) 2007-09-20
EP1421974B1 (de) 2006-12-06
EP1421974A1 (de) 2004-05-26
DE60216612D1 (de) 2007-01-18

Similar Documents

Publication Publication Date Title
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
WO2002092026A3 (en) Dermatological and cosmetic compositions
DE60035232D1 (de) (S,S)-Reboxetine zur Behandlung von chronischen Erschöpfungssyndrom
MY142329A (en) Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents.
WO2002036562A3 (en) 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
BR0215551A (pt) Composição de tratamento de pele úmida e processo de umidificação e proteção da pele
BR0010704A (pt) Composições e métodos de anti-náusea
BR0313676A (pt) Derivados de pirimidina e uso destes como moduladores cb2
FR2842201B1 (fr) Nouvel oligosaccharide, compositions cosmetiques et/ou dermatologiques en contenant et ses applications
BR0318278A (pt) compostos de éter aminocicloexìlico e usos dos mesmo
BR0012696A (pt) Composição oftálmica
BRPI0601467A (pt) dispositivo cosmético compreendendo trama não articulada
DE50206761D1 (de) Fluorhaltige copolymere, deren herstellung und verwendung
EP1736470A3 (de) Pyrimidin-Derivate als cb2 Cannabinoid-Rezeptor Modulatoren
BRPI0411085A (pt) composto, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de vìrus oncogênicos, e de condições ou distúrbios devidos a infecção por hpv
BR0311874A (pt) Uso de nefopam para o tratamento de náusea ou emese
AU2003273843A1 (en) Use of skin-protecting substances
NO20014240L (no) C16-umettede FP-selektive prostaglandinanaloger
BRPI0511125A (pt) usos de ácido 5,6,7-triidroxieptanóico seus e análogos
WO2005056515A3 (en) Use of bis-amines to enhance the antimicrobial activity of aqueous compositions
CY1106409T1 (el) Παραγωγα κινολινης
ATE347398T1 (de) Carboxy methyl beta-1,3 glucan enthaltende ophthalmische lösung
CA2264094A1 (en) Structured water for enhanced moisturization
ATE469882T1 (de) Neue verbindungen, die sich f r die behandlung von durch ppar vermittelten krankheiten eignen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties